Related Experiment Video
Updated: Jul 6, 2026
07:34
Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays
M Burchardt1, R Engers, M Müller
1Department of Urology, Medizinische Hochschule Hannover, Carl-Neuberg Strasse 1, Hannover, Germany. burchardt.martin@mh-hannover.de
Journal of Cancer Research and Clinical Oncology
|April 9, 2008
Summary
German pathologists frequently under-graded small prostate cancers (PCa) on tissue microarray (TMA) images. Accurate Gleason scoring for treatment planning was achieved in only 68% of cases, highlighting a challenge for pathologists with less experience in evaluating small PCas.
Area of Science:
- Pathology
- Oncology
- Urology
Background:
- Prostate cancer (PCa) is increasingly diagnosed at earlier stages due to PSA screening.
- Earlier diagnosis results in smaller prostate needle biopsy samples.
- Accurate Gleason grading is crucial for effective prostate cancer treatment planning.
Purpose of the Study:
- To evaluate interobserver variability in Gleason grading of small prostate cancers among German pathologists.
- To assess the accuracy of Gleason scoring on tissue microarray (TMA) images.
- To identify factors influencing grading accuracy.
Main Methods:
- A controlled study involving 29 German pathologists evaluating 331 TMA images of prostate cancer.
- Images were presented digitally via the Bacus Webslide Browser.
- Pathologists' Gleason scores were compared anonymously to an expert pathologist's assessment.
Main Results:
- An average of 45.7% of TMA images received the same Gleason score as the expert.
- 83.5% of samples had Gleason scores differing by no more than one point.
- 68.3% of cases were correctly assigned to clinically relevant Gleason score categories (<7, 7, >7).
- 75.9% of participants under-graded the TMA images.
- Higher weekly biopsy evaluation volume correlated with better Gleason grading agreement.
Conclusions:
- A significant proportion of German pathologists under-grade small prostate cancers.
- Correct assignment to clinically relevant Gleason score categories remains a challenge.
- This variability poses a potential problem for treatment planning, especially for pathologists with limited experience in evaluating small PCas.
